骨誘導因子(OGN)多克隆抗體

Polyclonal Antibody to Osteoglycin (OGN)

OIF; SLRR3A; Mimecan Proteoglycan; Osteoinductive Factor

  • 骨誘導因子(OGN)多克隆抗體產(chǎn)品包裝(模擬)
  • 骨誘導因子(OGN)多克隆抗體產(chǎn)品包裝(模擬)
  • 骨誘導因子(OGN)多克隆抗體DAB staining on IHC-P; Samples: Human Liver Tissue; Primary Ab: 20μg/ml Rabbit Anti-Human OGN Antibody Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody (Catalog: SAA544Rb19)
  • 骨誘導因子(OGN)多克隆抗體DAB staining on IHC-P;
    Sample: Human Liver Tissue
    Primary Ab: 20μg/ml Rabbit Anti-Human OGN Antibody
    Control: Used PBS instead of primary antibody
    Second Ab: 2μg/ml HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
    (Catalog: SAA544Rb19)
  • PAC688Hu01.jpgWB圖
  • 骨誘導因子(OGN)多克隆抗體Western Blot; Sample: Human Lung lysate;
    Primary Ab: 1μg/ml Rabbit Anti-Human OGN Antibody
    Second Ab: 0.2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
    (Catalog: SAA544Rb19)
  • 骨誘導因子(OGN)多克隆抗體Western Blot; Sample: Human Liver lysate;
    Primary Ab: 1μg/ml Rabbit Anti-Human OGN Antibody
    Second Ab: 0.2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
    (Catalog: SAA544Rb19)
  • Certificate通過ISO 9001、ISO 13485質(zhì)量體系認證

特異性

該抗體是針對OGN的兔多克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別OGN。

用法

Western blotting: 0.01-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.

儲存

經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。

穩(wěn)定性

熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當?shù)臈l件下存儲，損失率低于5%。

贈品

相關產(chǎn)品

編號適用物種：Homo sapiens (Human，人)應用(僅供研究使用，不用于臨床診斷！)
RPC688Hu01骨誘導因子(OGN)重組蛋白Positive Control; Immunogen; SDS-PAGE; WB.
PAC688Hu01骨誘導因子(OGN)多克隆抗體WB; IHC
LAC688Hu71骨誘導因子(OGN)多克隆抗體(生物素標記)WB; IHC; ICC.
MAC688Hu22骨誘導因子(OGN)單克隆抗體WB; IHC; ICC; IP.
SEC688Hu骨誘導因子(OGN)檢測試劑盒(酶聯(lián)免疫吸附試驗法)Enzyme-linked immunosorbent assay for Antigen Detection.
LMC688Hu骨誘導因子(OGN)等多因子檢測試劑盒(流式熒光發(fā)光法)FLIA Kit for Antigen Detection.

參考文獻

雜志參考文獻
Bone.Association of osteoglycin and FAM5C with bone turnover markers, bone mineral density, and vertebral fractures in postmenopausal women with type 2 diabetes mellitus.[pubmed:27836731]
Tohoku journal of experimental medicineHigher Serum Levels of Osteoglycin Are Associated with All-Cause Mortality and Cardiovascular and Cerebrovascular Events in Patients with Advanced Chronic Kidney Disease.[pubmed:28824047]
Molecular MetabolismOsteoglycin, a novel coordinator of bone and glucose homeostasis[Pubmed:29799418]
Journal of Experimental &?Clinical?Cancer?ResearchOsteoglycin (OGN) reverses epithelial to mesenchymal transition and invasiveness in colorectal cancer via EGFR/Akt pathway[Pubmed:29499765]
Journal of Human HypertensionAssociation of SLRPs with carotid artery atherosclerosis in essential hypertensive patients[Pubmed:29867136]
Cell?ReportsTransforming Growth Factor-β3 Regulates Adipocyte Number in Subcutaneous White Adipose Tissue[Pubmed: 30332637]
J Clin Endocrinol MetabOsteoglycin across the adult lifespan[34850904]